期刊
SLEEP MEDICINE REVIEWS
卷 26, 期 -, 页码 64-73出版社
W B SAUNDERS CO LTD
DOI: 10.1016/j.smrv.2015.04.001
关键词
Intrauterine growth restriction; Sleep; Preterm birth; Cardiovascular control; Melatonin
资金
- National Health and Medical Research Council (NHMRC) of Australia [1045559]
- NHMRC Senior Research Fellowship (RSCH) [606411]
- Victorian Government's Operational Infrastructure Support Program
- National Health and Medical Research Council of Australia [606411] Funding Source: NHMRC
Intrauterine growth restriction (IUGR) complicates 5-10% of pregnancies and is associated with increased risk of preterm birth, mortality and neurodevelopmental delay. The development of sleep and cardiovascular control are closely coupled and IUGR is known to alter this development. In the long-term, IUGR is associated with altered sleep and an increased risk of hypertension in adulthood. Melatonin plays an important role in the sleep-wake cycle. Experimental animal studies have shown that melatonin therapy has neuroprotective and cardioprotective effects in the IUGR fetus. Consequently, clinical trials are currently underway to assess the short and long term effects of antenatal melatonin therapy in IUGR pregnancies. Given melatonin's role in sleep regulation, this hormone could affect the developing infants' sleep-wake cycle and cardiovascular function after birth. In this review, we will 1) examine the role of melatonin as a therapy for IUGR pregnancies and the potential implications on sleep and the cardiovascular system; 2) examine the development of sleep-wake cycle in fetal and neonatal life; 3) discuss the development of cardiovascular control during sleep; 4) discuss the effect of IUGR on sleep and the cardiovascular system and 5) discuss the future implications of melatonin therapy in IUGR pregnancies. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据